0001831908-20-000001.txt : 20201215 0001831908-20-000001.hdr.sgml : 20201215 20201215134117 ACCESSION NUMBER: 0001831908-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 EFFECTIVENESS DATE: 20201215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pluto Immunotherapeutics, Inc. CENTRAL INDEX KEY: 0001831908 IRS NUMBER: 845089227 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383243 FILM NUMBER: 201389077 BUSINESS ADDRESS: STREET 1: 907 WESTWOOD BLVD, STE 1086 CITY: LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: 818-314-1910 MAIL ADDRESS: STREET 1: 907 WESTWOOD BLVD, STE 1086 CITY: LOS ANGELES STATE: CA ZIP: 90024 D 1 primary_doc.xml X0708 D LIVE 0001831908 Pluto Immunotherapeutics, Inc. 907 WESTWOOD BLVD, STE 1086 LOS ANGELES CA CALIFORNIA 90024 818-314-1910 DELAWARE None None Corporation true 2020 Mark Cohen 1500 Broadway New York NY NEW YORK 10036 Director Christopher Seet 1555 South Carmelina Ave Los Angeles CA CALIFORNIA 90025 Director Amelie Montel-Hagen 10585 Missouri Avenue Los Angeles CA CALIFORNIA 90025 Director Gay Miriam Crooks 14251 Roblar Place Sherman Oaks CA CALIFORNIA 91423 Director Other Health Care Decline to Disclose 06b false 2020-10-12 false true true Simple Agreement for Future Equity false 25000 2200000 2200000 0 false 30 0 0 0 false Pluto Immunotherapeutics, Inc. /s/ Mark Cohen Mark Cohen Director 2020-12-15